Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK - Voysey, M; Clemens, S AC; Madhi, S A; Oxford COVID Vaccine Trial Group (Lancet, 2021)
(10269):